CompletedNot Applicable

Dydrogesterone Versus Intravaginal Progesterone in the Luteal Phase Support

Croatia853 participantsStarted 2010-10

Plain-language summary

The purpose of this study is to compare efficacy and tolerability of the dydrogesterone and the vaginal progesterone, used for luteal phase support. (Initial start date was January 2009 but not for patients' recruitment only for paper work, documents, team organization, statistical pre-work actions and to gain the official approval of Institutional Review Board. The recruitment started in October 2010 and continued until October 2013.)

Who can participate

Age range18 Years – 45 Years

SexFEMALE

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * routine ovulation induction protocol with GnRH agonist * less than three prior IVF cycles * at least three aspirated oocytes * BMI \<35 kg/m2 * age \<45 years Exclusion Criteria: * history of dysfunctional uterine bleeding * acute urogenital disease * recurrent miscarriage * previous allergic reactions to a progesterone products

What they're measuring

Ongoing pregnancy rate

Timeframe: 12 weeks

Trial details

NCT IDNCT01178931

SponsorUniversity of Zagreb

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2013-10

View on ClinicalTrials.gov More Luteal Phase Defect trials